Mostrando 5 resultados de: 5
Filtros aplicados
Publisher
American Journal of Therapeutics(3)
Archivos Venezolanos de Farmacologia y Terapeutica(1)
Revista Latinoamericana de Hipertension(1)
Área de conocimiento
Enfermedad cardiovascular(2)
Farmacología(2)
Medicina interna(2)
Diabetes(1)
Fisiología(1)
Origen
scopus(5)
Cigarette smoking and cardiovascular disease
ReviewAbstract: Cigarette smoking is considered a risk factor for many diseases especially for cardiovascular diseasPalabras claves:Cardiovascular disease, risk factor, smokingAutores:Aguirre M.A., Aparicio D., Bustamante M., Canelón R., Finol F., Luis Xavier Enríquez Acosta, Urdaneta A., Valmore Bermúdez, Velasco M.Fuentes:scopusAn elevated level of physical activity is associated with normal lipoprotein(a) levels in individuals from Maracaibo, Venezuela
ArticleAbstract: Coronary artery disease is the main cause of death worldwide. Lipoprotein(a) [Lp(a)], is an independPalabras claves:Cardiovascular Risk, Lifestyle, lipoprotein(a), Physical activityAutores:Acosta L., Añez-Ramos R., Aparicio D., Arráiz N., Cano R.A., Cano-Ponce C., Colmenares C., Faria J., Finol F., Mengual-Moreno E., Peñaranda L., Pineda C., Rodriguez D., Rojas E.R., Rojas-Quintero J., Sanchez W., Sorell L.T., Toledo A.C., Urribarí J., Valmore Bermúdez, Velasco M.Fuentes:scopusPPAR-γ agonists and their role in type 2 diabetes mellitus management
ReviewAbstract: Type 2 diabetes mellitus and obesity are the most frequent endocrine-metabolic diseases in the worldPalabras claves:diabetes mellitus, Insulin Resistance, PPARI, ThiazolidenedionesAutores:Arráiz N., Finol F., Parra M.G., Parra N., Peñaranda L., Pérez A., Rojas-Quintero J., Valmore Bermúdez, Velasco M., Vílchez D.Fuentes:scopusInsulin resistance and hyperinsulinemia as risk factors for cardiovascular disease
Conference ObjectAbstract: Insulin resistance is defined as a metabolic state in which insulin peripheral effects are diminishePalabras claves:Cardiovascular disease, Hiperinsulinemia, Insulin, Insulin ResistanceAutores:Acosta L., Aparicio D., Arráiz N., Canelón R., Cano R.A., Deisiree S., Finol F., Leal E.M., Linares S., Luti Y., Rojas E.R., Rojas-Quintero J., Valmore BermúdezFuentes:scopusPharmacologic management of isolated low high-density lipoprotein syndrome
ArticleAbstract: High-density lipoprotein (HDL) cholesterol is a heterogeneous group of lipoproteins exhibiting a varPalabras claves:atherosclerosis, cholesterol, Coronary artery disease, dyslipidemia, HDLc, Reverse cholesterol transportAutores:Acosta L., Amell A., Arráiz N., Bermúdez F.A., Cano R.A., Cano-Ponce C., Finol F., Hernández-Hernandez R., Hidalgo J., Kendall P., Manuel V., Pabón M.R., Reyna-Villasmil N., Valmore BermúdezFuentes:scopus